Flyrcado
Payments companies reported to CMS as associated with Flyrcado. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Flyrcado, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Flyrcado
These are the largest totals companies reported as associated with Flyrcado. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| James Case | Orange, CT | Endocrinology, Diabetes & Metabolism | $33,681.00 |
| Mouaz Al-Mallah | Detroit, MI | Cardiovascular Disease | $12,600.00 |
| Rupa Sanghani | Chicago, IL | Cardiovascular Disease | $7,200.00 |
| Jamieson Bourque | Charlottesville, VA | Cardiovascular Disease | $5,100.00 |
| Panithaya Chareonthaitawee | Rochester, MN | Cardiovascular Disease | $4,000.00 |
| Mahmoud Alrifai | Houston, TX | Cardiovascular Disease | $3,513.00 |
| Marcelo Di Carli | Boston, MA | Nuclear Cardiology | $2,400.00 |
Prescribed Flyrcado?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.